Atherogenic diet-induced hepatitis is partially dependent on murine TLR4

Journal of Leukocyte Biology

Volumn 83, Issue 6, 2008, Pages 1336-1344

  Desai, Moreshwar S ^a   Mariscalco, M Michele ^a   Tawil, Ahmad ^a   Vallejo, J G ^b   Smith, C W ^a,b  

^a CHILDREN S NUTRITION RESEARCH CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokines; Cholesterol cholate diet; Inflammation; TLR2

Indexed keywords

CHOLESTEROL; CHOLIC ACID; GAMMA INTERFERON; INTERLEUKIN 6; LIVER ENZYME; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 4; CCL2 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; MESSENGER RNA; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROMA; CELL INFILTRATION; CONTROLLED STUDY; FATTY LIVER; GENE DELETION; HEPATITIS; HYPERCHOLESTEROLEMIA; LIVER FIBROSIS; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STONE FORMATION; WILD TYPE; ANIMAL; C57BL MOUSE; CHOLESTEROL INTAKE; FAT INTAKE; GENETICS; PHYSIOLOGY;

ANIMALIA; MURINAE; MUS;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CXCL2; CHOLESTEROL, DIETARY; CHOLIC ACID; DIET, ATHEROGENIC; DIETARY FATS; FATTY LIVER; HEPATITIS; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 45949106221     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0607390     Document Type: Article

References (52)

1. Nishina, P. M., Verstuyft, J., Paigen, B. (1990) Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31, 859-869.
2. Stokes, K. Y. (2006) Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. Antioxid. Redox Signal. 8, 1141-1151.
3. Stokes, K. Y., Cooper, D., Tailor, A., Granger, D. N. (2002) Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic. Biol. Med. 33, 1026-1036.
4. Gauthier, T. W., Scalia, R., Murohara, T., Guo, J. P., Lefer, A. M. (1995) Nitric-oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15, 1652-1659.
5. Stokes, K. Y., Clanton, E. C., Bowles, K. S., Fuseler, J. W., Chervenak, D., Chervenak, R., Jennings, S. R., Granger, D. N. (2002) The role of Tlymphocytes in hypercholesterolemia-induced leukocyte-endothelial interactions. Microcirculation 9, 407-417.
6. Stokes, K. Y., Clanton, E. C., Clements, K. P., Granger, D. N. (2003) Role of interferon-γ in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation 107, 2140-2145.
7. Stokes, K. Y., Calahan, L., Russell, J. M., Gurwara, S., Granger, D. N. (2006) Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation 13, 377-388.
8. Getz, G. S., Reardon, C. A. (2006) Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 242-249.
9. Lammert, F., Wang, D. Q. H., Paigen, B., Carey, M. C. (1999) Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes. J. Lipid Res. 40, 2080-2090.
10. Wittenburg, H., Lyons, M. A., Paigen, B., Carey, M. C. (2003) Mapping cholesterol gallstone susceptibility (lith) genes in inbred mice. Dig. Liver Dis. 35, S2-S7.
11. Vergnes, L., Phan, J., Strauss, M., Tafuri, S., Reue, K. (2003) Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278, 42774-42784.
12. Hoekstra, M., Out, R., Kruijt, J. K., Van Eck, M., Van Berkel, T. J. C. (2005) Diet induced regulation of genes involved in cholesterol metabolism in rat liver parenchymal and Kupffer cells. J. Hepatol. 42, 400-407.
13. Jeong, W. I., Jeong, D. H., Do, S. H., Kim, Y. K., Park, H. Y., Kwon, O. D., Kim, T. H., Jeong, K. S. (2005) Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J. Vet. Med. Sci. 67, 235-242.
14. Kumar, S. A., Sudhahar, V., Varalakshmi, P. (2006) Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis. Atherosclerosis 189, 115-122.
15. Liao, F., Andalibi, A., Debeer, F. C., Fogelman, A. M., Lusis, A. J. (1993) Genetic-control of inflammatory gene induction and NF-κ-B-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91, 2572-2579.
16. Liao, F., Andalibi, A., Qiao, J. H., Allayee, H., Fogelman, A. M., Lusis, A. J. (1994) Genetic-evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94, 877-884.
17. Brown, M. S., Goldstein, J. L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
18. Ohashi, R., Mu, H., Wang, X., Yao, Q., Chen, C. (2005) Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 98, 845-856.
19. Frimmer, M., Ziegler, K. (1988) The transport of bile-acids in liver-cells. Biochim. Biophys. Acta 947, 75-99.
20. Otsubo, R., Higuchi, M. D. L., Gutierrez, P. S., Benvenuti, L. A., Massarollo, P. C. B., Costa, A. L., Ramires, J. A. F. (2006) Influence of chronic liver disease on coronary atherosclerosis vulnerability features. Int. J. Cardiol. 109, 387-391.
21. Toledo, F. G. S., Sniderman, A. D., Kelley, D. E. (2006) Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 29, 1845-1850.
22. Kullak-Ublick, G. A., Stieger, B., Meier, P. J. (2004) Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322-342.
23. Schwabe, R. F., Seki, E., Brenner, D. A. (2006) Toll-like receptor signaling in the liver. Gastroenterology 130, 1886-1900.
24. Janeway, C. A., Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
25. Akira, S., Takeda, K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511.
26. Huang, H., Liu, T., Rose, J. L., Stevens, R. L., Hoyt, D. G. (2007) Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet. J. Inflamm. (Lond.) 4, 22.
27. Xu, X. H., Shah, P. K., Faure, E., Equils, O., Thomas, L., Fishbein, M. C., Luthringer, D., Xu, X. P., Rajavashisth, T. B., Yano, J., Kaul, S., Arditi, M. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104, 3103-3108.
28. Bjorkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., Freeman, M. W. (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10, 416-421.
29. Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W. X., Yano, J. A., Doherty, T. M., Akira, S., Rajavashisth, T. B., Arditi, M. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101, 10679-10684.
30. Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., Witztum, J. L. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561-1568.
31. Schoneveld, A. H., Nijhuis, M. M. O., van Middelaar, B., Laman, J. D., de Kleijn, D., Pasterkamp, G. (2005) Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc. Res. 66, 162-169.
32. Bjorkbacka, H. (2006) Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr. Opin. Lipidol. 17, 527-533.
33. Mathurin, P., Deng, Q. G., Keshavarzian, A., Choudhary, S., Holmes, E. W., Tsukamoto, H. (2000) Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32, 1008-1017.
34. Howard, C. V., Reed, M. G. (1998) Estimation of component volume and volume fraction. In Unbiased Stereology (P. Goldby, ed.), Oxford, UK, Bios Scientific, Chapter 4.
35. Bligh, E. G., Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
36. Morrison, W. R., Smith, L. M. (1964) Preparation of fatty acid methyl esters and dimethylacetals from boron fluoride-methanol. J. Lipid Res. 5, 600-608.
37. Baumgarten, G., Knuefermann, P., Nozaki, N., Sivasubramanian, N., Mann, D. L., Vallejo, J. G. (2001) In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of Toll-like receptor-4. J. Infect. Dis. 183, 1617-1624.
38. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025.
39. Lee, J. Y., Sohn, K. H., Rhee, S. H., Hwang, D. (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689.
40. Szabo, G., Dolganiuc, A., Mandrekar, P. (2006) Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44, 287-298.
41. Qin, P., Borges-Marcucci, L. A., Evans, M. J., Harnish, D. C. (2005) Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G267-G273.
42. Evans, M. J., Eckert, A., Lai, K., Adelman, S. J., Harnish, D. C. (2001) Reciprocal antagonism between estrogen receptor and NF-κ B activity in vivo. Circ. Res. 89, 823-830.
43. Leifeld, L., Dumoulin, F. L., Purr, I., Janberg, K., Trautwein, C., Wolff, M., Manns, M. P., Sauerbruch, T., Spengler, U. (2003) Early up-regulation of chemokine expression in fulminant hepatic failure. J. Pathol. 199, 335-344.
44. Baggiolini, M. (1998) Chemokines and leukocyte traffic. Nature 392, 565-568.
45. Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J. H., Huber, J., Faull, K. F., Grass, D. S., Navab, M., Fogelman, A. M., de Beer, F. C., Lusis, A. J., Berliner, J. A. (1999) Role of group II secretory phospholipase A(2) in atherosclerosis-2. Potential involvement of biologically active oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 19, 1291-1298.
46. Van Lenten, B. J., Wagner, A. C., Navab, M., Fogelman, A. M. (2001) Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J. Biol. Chem. 276, 1923-1929.
47. Qin, P., Borges-Marcucci, L. A., Evans, M. J., Harnish, D. C. (2005) Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G267-G273.
48. Gutierrez, A., Ratliff, E. P., Andres, A. M., Huang, X. Q., McKeehan, W. L., Davis, R. A. (2006) Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. Arterioscler. Thromb. Vasc. Biol. 26, 301-306.
49. Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zahringer, U., Beutler, B. (2005) CD36 is a sensor of diacylglycerides. Nature 433, 523-527.
50. Den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., Romijn, J. A. (2004) Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler. Thromb. Vasc. Biol. 24, 644-649.
51. Goudriaan, J. R., Dahlmans, V. E. H., Teusink, B., Ouwens, D. M., Febbraio, M., Maassen, J. A., Romijn, J. A., Havekes, L. M., Voshol, P. J. (2003) CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J. Lipid Res. 44, 2270-2277.
52. Goudriaan, J. R., Febbraio, M., Kales, A. J., Ouwens, M. D., Teusink, B., Romijn, J. A., Havekes, A. M., Voshol, P. J. (2003) Hyperlipidemic CD36-deficient mice show increased insulin sensitivity in muscle, but hepatic insulin resistance. Circulation 108, 198.